Melhores Quimioterapia para Sarcomas médicos em Israel - TOP-5 médicos

O Professor Ofer Merimsky chefia a Unidade de Oncologia de Tecidos Moles e Ósseos no Centro Médico Sourasky, com uma carreira notável que abrange décadas no tratamento de sarcomas.

• Especialista em quimioterapia para sarcomas desde 1995
• Membro do corpo docente da ESMO para protocolos de tratamento de sarcomas
• Realizou uma formação de especialização (Fellowship) no Institut Gustave Roussy, em Paris
• Publicou extensivamente sobre os resultados do tratamento de sarcomas

Mais de 300 transplantes de medula óssea e sangue de cordão umbilical – O Dr. El Hasid lidera a onco-hematologia pediátrica no Hospital Infantil Dana Dwek.

• Chefe do Departamento de Onco-Hematologia e Oncologia Pediátrica
• Membro da Associação Americana de Hematologia
• Publicou 50 artigos e apresentou 40 relatórios em conferências
• Praticou no City of Hope Hospital em Los Angeles

O Dr. Dror Levin é especialista no tratamento de sarcoma em crianças no Sourasky Medical Center, coordenando o cuidado com equipes de oncologia ortopédica.

• Diretor de Hematologia Oncológica Pediátrica no Sourasky Medical Center
• Treinado no Instituto Ortopédico Rizzoli em Bolonha – um líder global no tratamento de sarcoma
• Membro da ISPHO (Israel Society of Pediatric Hematology Oncology)
• Especializado tanto em hematologia quanto em oncologia para casos pediátricos

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.